Evidera
Sohan Deshpande is a seasoned professional in the field of research and healthcare, currently serving as Senior Director at Evidera since 2018. Prior to this role, Sohan held positions as Director and Research Scientist at Kleijnen Systematic Reviews Ltd from June 2011 to February 2018, and as a Systematic Reviewer at the University of York from October 2010 to April 2011. Earlier experience includes an internship at the National AIDS Research Institute in Pune in 2009. Sohan's academic background includes a Master's degree in International Public Health/International Health from the University of York, in addition to Master's and Bachelor's degrees in Biotechnology from Dr. D. Y. Patil Vidyapeeth.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.